Neuland Laboratories (NSE:NEULANDLAB) OCF Yield %: 1.51 (As of Jun. 28, 2026)


NSE:NEULANDLAB Neuland Laboratories Ltd NSE:NEULANDLAB
90 GF Score
Price ₹17,961.00
GF Value ₹16,471.48
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Neuland Laboratories OCF Yield %?

Neuland Laboratories NSE:NEULANDLAB -0.61% 90 OCF Yield % is 1.51 as of Jun. 28, 2026. GuruFocus rates NSE:NEULANDLAB with a GF Score™ of 90/100 and a GF Value™ of ₹16,471.48 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Neuland Laboratories ranks worse than 61.29% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Neuland Laboratories's Trailing 12-Month Cash Flow from Operations is ₹0 Mil, and Market Cap is ₹230,137 Mil. Therefore, Neuland Laboratories's OCF Yield % for today is 1.51%.

The historical rank and industry rank for Neuland Laboratories's OCF Yield % or its related term are showing as below:

NSE:NEULANDLAB' s OCF Yield % Range Over the Past 10 Years
Min: 1.51   Med: 0   Max: 1.51
Current: 1.51


During the past 13 years, the highest OCF Yield % of Neuland Laboratories was 1.51%. The lowest was 1.51%. And the median was %.

NSE:NEULANDLAB's OCF Yield % is ranked worse than
61.29% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 3.61 vs NSE:NEULANDLAB: 1.51

Neuland Laboratories's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Neuland Laboratories OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Neuland Laboratories OCF Yield % Related Terms


Neuland Laboratories OCF Yield % Historical Data

* Premium members only.

The historical data trend for Neuland Laboratories's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuland Laboratories OCF Yield % Chart

Neuland Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.57 10.25 3.22 2.05 2.25

Neuland Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:NEULANDLAB vs ZTS: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's OCF Yield % falls into.


NSE:NEULANDLAB
90GF Score
Neuland Laboratories Ltd NSE:NEULANDLAB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuland Laboratories OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Neuland Laboratories's OCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=3466.804 / 154306.41
=2.25%

Neuland Laboratories's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 154306.41
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 1.51 mean?
Neuland Laboratories (NSE:NEULANDLAB) has a OCF Yield % of 1.51 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Neuland Laboratories and its competitors. Over the past decade, Neuland Laboratories' OCF Yield % has ranged from 1.51 to 1.51. According to the industry distribution chart, Neuland Laboratories ranks #616 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 61.3%.
Is Neuland Laboratories' OCF Yield % too high?
Neuland Laboratories' current OCF Yield % is 1.51. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 1.51. The Drug Manufacturers industry median OCF Yield % is 3.61. Neuland Laboratories' value of 1.51 is 58.2% below this industry median. Based on the distribution chart, Neuland Laboratories ranks #616 out of 1005 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Neuland Laboratories has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neuland Laboratories' OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Neuland Laboratories ranks #616 out of 1005 companies for OCF Yield %. This places Neuland Laboratories in the lower half of its industry. The industry median OCF Yield % is 3.61. Neuland Laboratories' value of 1.51 is 58.2% below this benchmark. Historically, Neuland Laboratories' own OCF Yield % has ranged from 1.51 to 1.51 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuland Laboratories's current OCF Yield % of 1.51 is 58.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Neuland Laboratories and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuland Laboratories's current OCF Yield % is 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuland Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Neuland Laboratories (NSE:NEULANDLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹16,471.48, compared to a current price of ₹17,961.00 — trading 9% above its estimated fair value. The current OCF Yield % is 1.51 and 58.2% below the Drug Manufacturers industry median of 3.61. Neuland Laboratories' overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Neuland Laboratories (NSE:NEULANDLAB), the current OCF Yield % is 1.51 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuland Laboratories (NSE:NEULANDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Neuland Laboratories stock appears to be overvalued. The current stock price of ₹17,961.00 is trading 9% above its estimated GF Value™ of ₹16,471.48. GuruFocus considers Neuland Laboratories to be Fairly Valued.

Key valuation signals for NSE:NEULANDLAB:

  • OCF Yield %: 1.51
  • GF Value™: ₹16,471.48 vs. price of ₹17,961.00 (9% above fair value)
  • GF Score™: 90/100 with 2 warning signs
  • Industry Position: 58.2% below the Drug Manufacturers median (#616 of 1005)

No single metric tells the full story. See the NSE:NEULANDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuland Laboratories Business Description

Other Exchanges 524558:India
Address Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
90GF Score

Get the complete analysis for NSE:NEULANDLAB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹17,961.00
Price
₹16,471.48
GF Value